During the past decade, Iwate Medical University Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 17 clinical trials were completed, i.e. on average, 77.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 13 clinical trials were completed. i.e. 216.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Iwate Medical University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Iwate Medical University" with 3 trials sponsored, "Japan Clinical Cancer Research Organization" with 3 trials sponsored and "Takeda" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Iwate Medical University Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Asahi Kasei Medical Co., Ltd." with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator and "Japanese Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Iwate Medical University Hospital" are "Gastric Cancer" (4 trials), "Fallopian Tube Cancer" (3 trials), "Carcinoma, Transitional Cell" (2 trials), "Colorectal Cancer" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Iwate Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Iwate Medical University Hospital" are "Drug" (30 trials), "Device" (7 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Guselkumab" (3 trials), "Atezolizumab" (2 trials), "Docetaxel" (2 trials) and "Golimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Iwate Medical University Hospital" are 34 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Iwate Medical University Hospital". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Iwate Medical University Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Iwate Medical University Hospital, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".